Neurochem Res
Neurochemical Research
0364-3190
1573-6903
Kluwer Academic Publishers-Plenum Publishers
New York


1832150
17094036
9190
10.1007/s11064-006-9190-z
Original Paper


10
 Deficiency

Quinzii
Catarina M.



DiMauro
Salvatore



Hirano
Michio

+1-212-305-1048
+1-212-305-3986
mh29@columbia.edu



Department of Neurology, Columbia University Medical Center, New York, NY 10032 USA 

10
11
2006

4
2007

32
4-5
723
727
20
7
2006

3
10
2006


© Springer Science+Business Media, LLC 2006

10
10
10
10
10
10
10
 deficiency has been reported. The availability of genetic testing will allow for a better understanding of the pathogenesis of this disease and early initiation of therapy (even presymptomatically in siblings of patients) in this otherwise life-threatening infantile encephalomyopathy.

Keywords
CoQ10
Mitochondria
Encephalopathy
Myopathy
Cerebellar ataxia

issue-copyright-statement
© Springer Science+Business Media, LLC 2007




Introduction
10
10
10
1
2
10
1
1
10
1
Table 1
1
])

3
]

4
]

5
]

6
]

7
]

8
]

9
]

10
]

11
]




Fig. 1
10
10
COQ2-8
10





10
12
26
].
12
15
16
12
16
12
13
12
12
15
16
].
10
17
18
19
10
23
].
10
20
22
26
22
10
 is moderately reduced in skin fibroblasts.
24
25
]. In all the patients with different phenotypes, respiratory chain enzymes analyses show reduced activities of complex I + III and II + III with normal activities of isolated complex I and III.
10
1
), identification of the molecular genetic defect is not straightforward.
10
10
COQ1
17
].
10
COQ2
10
27
10
 biosynthesis.
APTX
10
10
28
29
31
10
10
10
10
 and cholesterol share a common biosynthetic pathway, therefore, in AOA1, altered levels of these molecules could be due to aberrant biosynthesis.
10
10
10
32
33
10
10
10
12
14
17
16
10
10
10
34
10
10
34
35
10
10
36
10
37
10
10
10
10
38
10
 deficiency could be another form of inherited ataxia due to oxidative damage, as vitamin E deficiency.
39
41
10
10
40
42
10
43
]. Larger studies are necessary to better define the short- and long-term effects of CoQ10 as primary or adjunctive therapy in neurodegenerative diseases.
10 
10
APTX
10
10
 deficiency syndrome will reveal new causes, enhance our understanding of its pathogenesis, and may provide novel insights that may be relevant to other neurodegenerative diseases.


References
1.
Turunen
M

Olsson
J

Dallner
G


Metabolism and function of coenzyme Q
Biochim Biophys Acta
2004
1660
171
199
10.1016/j.bbamem.2003.11.012

14757233


2.
Crane
FL

Hatefi
Y

Lester
RL

Widmer
C


Isolation of a quinone from beef heart mitochondria
Biochim Biophys Acta
1957
25
220
221
10.1016/0006-3002(57)90457-2

13445756


3.
Santos-Ocana
C

Do
TQ

Padilla
S

Navas
P

Clarke
CF


bc
1 complex stability in yeast coq mutants
J Biol Chem
2002
277
10973
10981
10.1074/jbc.M112222200

11788608


4.
Sun
IL

Sun
EE

Crane
FL

Morre
DJ

Lindgren
A

Low
H


Requirement for coenzyme Q in plasma membrane electron transport
Proc Natl Acad Sci USA
1992
89
11126
11130
10.1073/pnas.89.23.11126

1454789


5.
Villalba
JM

Navas
P


Plasma membrane redox system in the control of stress-induced apoptosis
Antioxid Redox Signal
2000
2
213
230

11229527


6.
Walter
L

Miyoshi
H

Leverve
X

Bernardi
P

Fontaine
E


Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report
Free Radic Res
2002
36
405
412
10.1080/10715760290021252

12069104


7.
Cornell
BA

Keniry
MA

Post
A

Robertson
RN

Weir
LE

Westerman
PW


Location and activity of ubiquinone 10 and ubiquinone analogues in model and biological membranes
Biochemistry
1987
26
7702
7707
10.1021/bi00398a025

3322405


8.
Turunen
M

Wehlin
L

Sjoberg
M

Lundahl
J

Dallner
G

Brismar
K

Sindelar
PJ


Beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10
Biochem Biophys Res Commun
2002
296
255
260
10.1016/S0006-291X(02)00871-9

12163010


9.
Watts
GF

Playford
DA

Croft
KD

Ward
NC

Mori
TA

Burke
V


Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus
Diabetologia
2002
45
420
426
10.1007/s00125-001-0760-y

11914748


10.
Saiki
R

Ogiyama
Y

Kainou
T

Nishi
T

Matsuda
H

Kawamukai
M


Pleiotropic phenotypes of fission yeast defective in ubiquinone-10 production. A study from the abc1Sp (coq8Sp) mutant
Biofactors
2003
18
229
235

14695938


11.
Bader
MW

Xie
T

Yu
CA

Bardwell
JC


Disulfide bonds are generated by quinone reduction
J Biol Chem
2000
275
26082
26088
10.1074/jbc.M003850200

10854438


12.
Ogasahara
S

Engel
AG

Frens
D

Mack
D


Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy
Proc Natl Acad Sci USA
1989
86
2379
2382
10.1073/pnas.86.7.2379

2928337


13.
Sobreira
C

Hirano
M

Shanske
S

Keller
RK

Haller
RG

Davidson
E



Mitochondrial encephalomyopathy with coenzyme Q10 deficiency
Neurology
1997
48
1238
1243

9153450


14.
Di Giovanni
S

Mirabella
M

Spinazzola
A

Crociani
P

Silvestri
G

Broccolini
A



Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency
Neurology
2001
57
515
518

11502923


15.
Boitier
E

Degoul
F

Desguerre
I

Charpentier
C

Francois
D

Ponsot
G



A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency
J Neurol Sci
1998
156
41
46
10.1016/S0022-510X(98)00006-9

9559985


16.
Aure
K

Benoist
JF

Ogier Baulny
H

Romero
NB

Rigal
O

Lombes
A


Progression despite replacement of a myopathic form of coenzyme Q10 defect
Neurology
2004
63
727
729

15326254


17.
Rotig
A

Appelkvist
EL

Geromel
V

Chretien
D

Kadhom
N

Edery
P



Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency
Lancet
2000
356
391
395
10.1016/S0140-6736(00)02531-9

10972372


18.
Rahman
S

Hargreaves
I

Clayton
P

Heales
S


Neonatal presentation of coenzyme Q10 deficiency
J Pediatr
2001
139
456
458
10.1067/mpd.2001.117575

11562630


19.
Salviati
L

Sacconi
S

Murer
L

Zacchello
G

Franceschini
L

Laverda
AM



Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition
Neurology
2005
65
606
608
10.1212/01.wnl.0000172859.55579.a7

16116126


20.
Musumeci
O

Naini
A

Slonim
AE

Skavin
N

Hadjigeorgiou
GL

Krawiecki
N



Familial cerebellar ataxia with muscle coenzyme Q10 deficiency
Neurology
2001
56
849
855

11294920


21.
Lamperti
C

Naini
A

Hirano
M

Vivo
DC

Bertini
E

Servidei
S



Cerebellar ataxia and coenzyme Q10 deficiency
Neurology
2003
60
1206
1208

12682339


22.
Gironi
M

Lamperti
C

Nemni
R

Moggio
M

Comi
G

Guerini
FR



Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency
Neurology
2004
62
818
820

15007142


23.
Maldergem
L

Trijbels
F

DiMauro
S

Sindelar
PJ

Musumeci
O

Janssen
A



Coenzyme Q-responsive Leigh’s encephalopathy in two sisters
Ann Neurol
2002
52
750
754
10.1002/ana.10371

12447928


24.
Lalani
SR

Vladutiu
GD

Plunkett
K

Lotze
TE

Adesina
AM

Scaglia
F


Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency
Arch Neurol
2005
62
317
320
10.1001/archneur.62.2.317

15710863


25.
Horvath
R

Schneiderat
P

Schoser
BG

Gempel
K

Neuen-Jacob
E

Ploger
H



Coenzyme Q10 deficiency and isolated myopathy
Neurology
2006
66
253
255
10.1212/01.wnl.0000194241.35115.7c

16434667


26.
Artuch
R

Brea-Calvo
G

Briones
P

Aracil
A

Galván
M

Espinós
C



Cerebellar ataxia with coenzyme Q10 deficiency: Diagnosis and followup after coenzyme Q10 supplementation
J Neurol Sci
2006
246
153
158
10.1016/j.jns.2006.01.021

16677673


27.
Quinzii
C

Naini
A

Salviati
L

Trevisson
E

Navas
P

Dimauro
S



A Mutation in Para-Hydroxybenzoate-Polyprenyl Transferase (COQ2) Causes Primary Coenzyme Q10 Deficiency
Am J Hum Genet
2006
78
345
349
10.1086/500092

16400613


28.
Quinzii
CM

Kattah
AG

Naini
A

Akman
HO

Mootha
VK

DiMauro
S



Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation
Neurology
2005
64
539
541

15699391


29.
Date
H

Onodera
O

Tanaka
H

Iwabuchi
K

Uekawa
K

Igarashi
S



Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene
Nat Genet
2001
29
184
188
10.1038/ng1001-184

11586299


30.
Moreira
MC

Barbot
C

Tachi
N

Kozuka
N

Uchida
E

Gibson
T



The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin
Nat Genet
2001
29
189
193
10.1038/ng1001-189

11586300


31.
Ahel Rass
U

El-Khamisy
SF

Katyal
S

Clements
PM

McKinnon
PJ

Caldecott
KW

West
SC


The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates
Nature
2006
443
713
716
10.1038/nature05164

16964241


32.
James
AM

Cocheme
HM

Smith
RA

Murphy
MP


Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools
J Biol Chem
2005
280
21295
21312
10.1074/jbc.M501527200

15788391


33.
Bhagavan
HN

Chopra
RK


Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
Free Radic Res
2006
40
445
453
10.1080/10715760600617843

16551570


34.
Zhang
Y

Aberg
F

Appelkvist
EL

Dallner
G

Ernster
L


Uptake of dietary coenzyme Q supplement is limited in rats
J Nutr
1995
125
446
453

7876919


35.
Bentinger
M

Dallner
G

Chojnacki
T

Swiezewska
E


Distribution and breakdown of labeled coenzyme Q10 in rat
Free Radic Biol Med
2003
34
563
575
10.1016/S0891-5849(02)01357-6

12614845


36.
Matthews
RT

Yang
L

Browne
S

Baik
M

Beal
MF


Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
Proc Natl Acad Sci USA
1998
95
8892
8897
10.1073/pnas.95.15.8892

9671775


37.
Naini
A

Lewis
VJ

Hirano
M

DiMauro
S


Primary coenzyme Q10 deficiency and the brain
Biofactors
2003
18
145
152

14695930


38.
Turunen
M

Swiezewska
E

Chojnacki
T

Sindelar
P

Dallner
G


Regulatory aspects of coenzyme Q metabolism
Free Radic Res
2002
36
437
443
10.1080/10715760290021298

12069108


39.
Beal
MF


Mitochondrial dysfunction and oxidative damage in Alzheimer’s and Parkinson’s diseases and coenzyme Q10 as a potential treatment
J Bioenerg Biomembr
2004
36
381
386
10.1023/B:JOBB.0000041772.74810.92

15377876


40.
Shults
CW

Haas
R


Clinical trials of coenzyme Q10 in neurological disorders
Biofactors
2005
25
117
126

16873936


41.
Schapira
AH


Mitochondrial diseases
Lancet 1
2006
368
70
82
10.1016/S0140-6736(06)68970-8

Schapira AH (2006) Mitochondrial diseases. Lancet 1 368:70–82 

42.
Shults
C

Oakes
D

Kieburtz
K

Beal
MF

Haas
R

Plumb
S



Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
Arch Neurol
2002
59
1541
1550
10.1001/archneur.59.10.1541

12374491


43.
Hart
P

Lodi
R

Rajagopalan
B

Bradley
JL

Crilley
JG

Turner
C



Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up
Arch Neurol
2005
62
621
626
10.1001/archneur.62.4.621

15824263



Special issue dedicated to John P. Blass.




